iSpecimen (NASDAQ:ISPC) operates at the intersection of technology and bioscience by providing researchers with biospecimens they need for their studies, such as blood, tissues, and cells. The company harnesses technology to streamline the procurement process, making it more efficient for both suppliers and researchers. iSpecimen's projects predominantly focus on improving the availability of high-quality specimens from a diverse population, thereby fostering advancements in medical research and personalized medicine. Objectives include expanding its global network of healthcare providers, enhancing its proprietary technology platform for better user experience, and ultimately contributing to scientific discoveries by ensuring the seamless collection and distribution of specimens.